These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 24063613)
1. In vitro neutralization of HCV by goat antibodies against peptides encompassing regions downstream of HVR-1 of E2 glycoprotein. Tabll AA; Atef K; Bader El Din NG; El Abd YS; Salem A; Sayed AA; Dawood RM; Omran MH; El-Awady MK J Immunoassay Immunochem; 2014; 35(1):12-25. PubMed ID: 24063613 [TBL] [Abstract][Full Text] [Related]
2. Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2. El Abd YS; Tabll AA; El Din NG; Hosny Ael-D; Moustafa RI; El-Shenawy R; Atef K; El-Awady MK Virol J; 2011 Aug; 8():391. PubMed ID: 21819575 [TBL] [Abstract][Full Text] [Related]
3. Mouse monoclonal antibody towards e1 specific epitope blocks viral entry and intracellular viral replication in vitro. Tabll AA; Moustafa RI; El Abd YS; Bader El Din NG; El-Shenawy R; Yousef H; Hussein M; Dawood RM; Omran MH; El-Awady MK J Immunoassay Immunochem; 2014; 35(1):60-73. PubMed ID: 24063617 [TBL] [Abstract][Full Text] [Related]
4. A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization. Sasayama M; Shoji I; Adianti M; Jiang DP; Deng L; Saito T; Watanabe H; Kawata S; Aoki C; Hotta H J Med Virol; 2012 Feb; 84(2):229-34. PubMed ID: 22170542 [TBL] [Abstract][Full Text] [Related]
5. Mice Antibody Response to Conserved Nonadjuvanted Multiple Antigenic Peptides Derived from E1/E2 Regions of Hepatitis C Virus. Abdelhafez TH; Bader El Din NG; Tabll AA; Mashaly MM; Dawood RM; Yassin NA; El-Awady MK Viral Immunol; 2017 Jun; 30(5):359-365. PubMed ID: 28402196 [TBL] [Abstract][Full Text] [Related]
6. Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization. Anjum S; Wahid A; Afzal MS; Albecka A; Alsaleh K; Ahmad T; Baumert TF; Wychowski C; Qadri I; Penin F; Dubuisson J J Infect Dis; 2013 Dec; 208(11):1888-97. PubMed ID: 23908491 [TBL] [Abstract][Full Text] [Related]
7. Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference. Sautto G; Mancini N; Diotti RA; Solforosi L; Clementi M; Burioni R Antiviral Res; 2012 Oct; 96(1):82-9. PubMed ID: 22898087 [TBL] [Abstract][Full Text] [Related]
8. Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22⁺ B cells. Tabll A; El Abd Y; El Din NG; El Shenawy R; Abdelhafez TH; El Awady M; El-Mohamady H; Viazov S Hum Antibodies; 2013; 22(3-4):55-65. PubMed ID: 24961863 [TBL] [Abstract][Full Text] [Related]
9. New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles. Kachko A; Kochneva G; Sivolobova G; Grazhdantseva A; Lupan T; Zubkova I; Wells F; Merchlinsky M; Williams O; Watanabe H; Ivanova A; Shvalov A; Loktev V; Netesov S; Major ME Vaccine; 2011 Dec; 30(1):69-77. PubMed ID: 22041300 [TBL] [Abstract][Full Text] [Related]
10. Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats. El-Awady MK; Tabll AA; El-Abd YS; Yousif H; Hegab M; Reda M; El Shenawy R; Moustafa RI; Degheidy N; El Din NG Virol J; 2009 May; 6():66. PubMed ID: 19473491 [TBL] [Abstract][Full Text] [Related]
11. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment. Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283 [TBL] [Abstract][Full Text] [Related]
12. A laboratory-adapted HCV JFH-1 strain is sensitive to neutralization and can gradually escape under the selection pressure of neutralizing human plasma. Song H; Ren F; Li J; Shi S; Yan L; Gao F; Li K; Zhuang H Virus Res; 2012 Oct; 169(1):154-61. PubMed ID: 22846920 [TBL] [Abstract][Full Text] [Related]
13. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Bartosch B; Bukh J; Meunier JC; Granier C; Engle RE; Blackwelder WC; Emerson SU; Cosset FL; Purcell RH Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14199-204. PubMed ID: 14617769 [TBL] [Abstract][Full Text] [Related]
14. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655 [TBL] [Abstract][Full Text] [Related]
15. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus. Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus with a naturally occurring single amino-acid substitution in the E2 envelope protein escapes neutralization by naturally-induced and vaccine-induced antibodies. Duan H; Struble E; Zhong L; Mihalik K; Major M; Zhang P; Feinstone S; Feigelstock D Vaccine; 2010 Jun; 28(25):4138-44. PubMed ID: 20433800 [TBL] [Abstract][Full Text] [Related]
18. Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice. Akazawa D; Moriyama M; Yokokawa H; Omi N; Watanabe N; Date T; Morikawa K; Aizaki H; Ishii K; Kato T; Mochizuki H; Nakamura N; Wakita T Gastroenterology; 2013 Aug; 145(2):447-55.e1-4. PubMed ID: 23673355 [TBL] [Abstract][Full Text] [Related]
19. [Study of neutralization antibodie induced by DNA vaccine of HCV envelope protein 2 in mice]. Shao S; Zhou H; Tong Y; Ren Y; Chen Z Wei Sheng Yan Jiu; 2011 May; 40(3):295-8. PubMed ID: 21695897 [TBL] [Abstract][Full Text] [Related]
20. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Zibert A; Schreier E; Roggendorf M Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]